GLP-1 receptor agonists may reduce the risk of developing and dying from substance use disorders, a study found. The study, led by researchers at St. Louis-based WashU Medicine and published March 4 in The BMJ, analyzed data from more than…
Author: Ella Jeffries
At Cedar Crest Hospital in Belton, Texas, pharmacy leadership spent the past year focused on one core shift: modernizing medication distribution to improve safety in a high-risk psychiatric setting. Edith Okolo, PharmD, director of pharmacy, said 2025 marked a major…
Lawrence, Kan.-based LMH Health has expanded use of a collaborative care model across its primary care clinics to address growing mental health needs. The evidence-based approach integrates behavioral health services into primary care, allowing patients with moderate depression or anxiety…
